WESTPORT, CT (January 16, 2023) – Q30 Innovations is pleased to announce the additions of Vice Admiral Tim Szymanski and Lieutenant General John Mulholland to its Board of Military Advisors. The company continues to see increased adoption of the Q-Collar throughout the military as more warfighters experience the benefits of the product designed and proven to reduce brain injury caused by repetitive subconcussive impacts.
By adding these two new members to its Board of Military Advisors, Q30 hopes to drive increased awareness for a broad range of military and law enforcement applications and continue to advance additional research around the product’s effectiveness in military-specific scenarios, including reducing brain injury caused by blast waves.
“As we continue to see adoption of the Q-Collar by military servicemen and women, Vice Admiral Szymanski and Lieutenant General Mulholland will provide valuable experience and firsthand military knowledge to our mission to help protect men and women who are at risk of traumatic brain injuries,” said Q30’s Co-CEO Tom Hoey. “We are proud and extremely honored to be supported by these decorated veterans who share our concern for the health and well-being of those who serve.”
Vice Admiral Tim Szymanski (Ret)
Vice Adm. Szymanski has served in a number of Navy and Joint Special Operations assignments as a Navy Special Warfare Officer (SEAL) for over 36 years. He most recently served as the Deputy Commander for United States Special Operations Command after previously serving as the Commander of Naval Special Warfare. In both roles he oversaw the manning, equipping and training, and employment of NSW and joint special operations forces.
In addition to his dedicated time in the service, he also led initiatives to improve human performance and protect brain health across special operations. Szymanski developed programs to enhance cognitive performance and established policies to monitor and protect brain health improving the welfare and operational readiness of all special operations forces and their families.
“Q30 has an innovative product that, in my opinion, from all of the clinical research, can potentially reduce the long term effects of impact and blast exposure. The potential to significantly improve the welfare of our service members pushed me to join the Q30 team,” said Szymanski.
Lieutenant General John Mulholland (Ret)
After joining the 1st Special Forces Regiment in 1983, LTG Mulholland (Ret) commanded from the captain through lieutenant general level in Army and joint special operations forces: including serving as Deputy Commanding General, Joint Special Operations Command, as the Commanding General, United States Army Special Operations Command, and as the 15th Deputy Commander, United States Special Operations Command. His professional background and involvement throughout his military career have driven him to make and influence changes to better prepare the force for future conflict, and to better protect the force today and for tomorrow.
“As I was already involved in assisting other lines of effort regarding the brain health of active-duty military members and veterans, and have two sons and a daughter actively serving in the Army, joining the Q30 team just made sense,” said Mulholland.
He will dedicate his time to educate the senior leaders within our Special Operations and large military communities about the ways Q30 is reducing the consequences of the kinetic, concussive impacts to the brain that’s frequently incurred by our men and women in uniform.
About Q30 Innovations
Q30 Innovations was recently awarded a $2.8 million contract by the United States Army Medical Research and Development Command (USAMRDC) to prove the overall effectiveness of the Q-Collar. With the provided funds, further research and development of the Q-Collar will take place to demonstrate its ability to reduce blast-induced TBI as a safe, effective, and durable option for soldiers.
Based in Westport, Conn., Q30 Innovations’ mission is to help protect the brain from the effects of head impacts on the sports field and the battlefield. Since 2012, Q30 has worked with leading medical, academic, engineering and design institutions to research and develop the Q-Collar, an externally worn device that aids in the protection of the brain from the effects associated with repetitive sub-concussive head impacts. In February 2021, the Q-Collar became the first and only FDA-cleared protective equipment that helps protect individuals’ brains during head impacts. For more information, please visit www.q30.com/military.